Related Experiment Videos
Pharmacokinetic study of valproic acid in a neonate
Insights
Valproic acid pharmacokinetics in neonates show a prolonged half-life (t 1/2) that matures with age. Clearance (Cl) and half-life (t 1/2) in infants change significantly by 6 months, indicating developmental changes.
Area of Science:
- Pharmacology
- Pediatric Medicine
- Drug Metabolism
Background:
- Valproic acid is a widely used anticonvulsant medication.
- Understanding its pharmacokinetic profile in neonates and infants is crucial for safe and effective dosing.
Observation:
- A single neonate (39 weeks gestational age) received valproic acid at 24 days postpartum (7.5 mg/kg) and again at 6 months (13.5 mg/kg/day).
- Serum samples were collected over 24 hours at 24 days and 12 hours at 6 months.
- Pharmacokinetic parameters were calculated using a one-compartment model.
Findings:
- At 24 days postpartum, valproic acid exhibited a half-life (t 1/2) of 17.2 hours, clearance (Cl) of 0.18 ml/min/kg, and volume of distribution (Vd) of 0.28 liter/kg.
- By 6 months of age, clearance (Cl) increased to 0.53 ml/min/kg, half-life (t 1/2) decreased to 7.5 hours, and Vd remained similar (0.34 liter/kg).
- The neonate's half-life was shorter than in younger neonates but longer than in adults.
Implications:
- Hepatic enzyme maturation and co-administration of other anticonvulsant drugs likely contribute to the observed changes in valproic acid pharmacokinetics.
- These findings highlight the importance of age-specific dosing adjustments for valproic acid in pediatric populations.
- Further research is warranted to elucidate the precise mechanisms driving these pharmacokinetic alterations.
Abstract:
Valproic acid was administered to a neonate (gestational age of 39 weeks) at 24 days post partum in an initial single dose of 7.5 mg/kg. Multiple serum samples were collected for 24 hours post dose. Valproic acid was continued and the study was repeated in the same child at 6 months of age at which time the dose had been increased to 13.5 mg/kg (27 mg/kg/day). Serum samples were collected for 12 hours post dose in this second study. A one-compartment model was assumed for calculation of the relevant pharmacokinetic parameters. The half-life (t 1/2) at 24 days of age was 17.2 hours, clearance (Cl) 0.18 ml/min/kg, and volume of distribution (Vd) 0.28 liter/kg. This t 1/2 was less than reported values in neonates younger than 10 days but longer than the average t 1/2 in adults. At 6 months of age, clearance had increased to 0.53 ml/min/kg, t 1/2 had decreased to 7.5 hours, while Vd was relatively unchanged (0.34 liter/kg). Factors possibly causing these changes include hepatic enzyme maturation and concomitant administration of anticonvulsant drugs.